Introduction: Lymph node metastasis is an important prognostic marker in penile cancer. Identification of occult metastasis is by lymphadenectomy based on the histological features of primary tumor; however, this leads to unnecessary surgical morbidity in node negative patients. Methods: A retrospective analysis of all surgically treated penile cancer patients managed at our institute from January 2011 to March 2014 was performed. Patient characteristics, histological factors, and lymph node involvement were identified. Logistic regression analysis was used to compute odds ratio (OR) in univariate and multivariate analysis. Results: Ninety seven patients underwent surgical management at our institute during the abovementioned period. Grade III tumor, presence of lymphovascular invasion, tumor thickness >10 mm, perineural invasion (PNI) and Ki67 >50% were significantly associated with nodal metastasis. On multivariate analysis, only presence of PNI was found to be significant (OR: 6.82) (95% confidence interval: 1.72–27.03) (p = 0.006). Conclusion: PNI is a strong independent predictor of occult lymph node metastasis in penile cancers. Its inclusion in stratification of clinically node negative patients will identify high-risk patients who will benefit from prophylactic lymphadenectomy.

Penile cancer is relatively uncommon malignancy affecting Indian men with a crude incidence rate of 1.18 per 100,000 population with a relatively higher incidence rate of 2.9 per 100,000 in South India [1]. Surgical management remains the mainstay of treatment for carcinoma penis. Inguinal lymphadenectomy remains an integral part of management for staging and therapeutic purpose; however, a subgroup of patients including stage Tis, Ta, and T1 can be closely observed as per the current guidelines [2]. We attempted to identify various pathological factors of the primary tumor that are associated with increased rate of nodal metastasis.

After approval from institutional ethical and regulatory board (Cancer Institute [WIA] Institutional Ethics Committee Approval No. IEC/2021/July 07), we performed a retrospective analysis on all patients with biopsy-proven penile cancer who underwent surgical treatment at our institute from January 2011 to March 2014. After histological confirmation, all patients underwent ultrasound of the abdomen and pelvis and chest X-ray as staging investigations. In nonmetastatic patients, management of primary disease was done by circumcision, partial amputation, or total amputation based on the extent of disease. All groins were initially staged by clinical examination and US-guided fine needle aspiration cytology. We performed cytology in all patients due to high incidence of palpable inguinal nodes seen in our country, with 1 series reporting an incidence of 96% as compared to 20% incidence in the West, probably due to barefoot walking [3]. In our study period of 3 ½ years, we changed our institutional policy for clinically and cytologically node negative patients, from observation initially to sentinel node biopsy or superficial inguinal block dissection. In the early years, cytologically negative patients were kept under observation, if the primary biopsy represented T1 and grade 1 disease. For higher stage or grade, a superficial inguinal block dissection was performed. In the subsequent years, after performing a validation study, a dynamic sentinel node biopsy using radiocolloid and blue dye was performed for cytologically negative patients, unless contraindicated [4]. In the event of histological node positivity or nodal recurrence, patients were subjected to completion ilioinguinal block dissection. Patients with cytologically node positive disease underwent ilioinguinal block dissection. For the purpose of the study, nodal status of patients in the observation group was based on uneventful follow-up of at least 24 months. As seen in the literature, nearly 86% of the recurrences tend to occur in the initial 2 years of follow-up; hence, this cutoff was decided [5]. Thus, patients who did not develop nodal recurrence after 2 years were assumed to be node negative. Patients on observation with shorter follow-up duration were excluded from the study.

The paraffin blocks of the specimen were retrieved and a single pathologist reviewed the blocks for the histological variables. Histological grading was done based on the categories specified by World Health Organization for penile cancer, including cytological atypia, keratinization, intercellular bridges, mitotic activity, and tumor margin. Based on the above criteria, they were graded into grade 1, well differentiated; grade 2, moderately differentiated; and grade 3, poorly differentiated. Patient who had received neoadjuvant therapy or who underwent surgical management elsewhere were not included in the analysis. The depth of invasion was measured from the basement membrane of the squamous epithelium to the deepest invasive carcinoma cell.

Immunohistochemistry for Ki67 was done after antigen retrieval in Tris-EDTA buffer at 100o C for 30 min. After peroxidase blocking for 10 min, the slides were stained with the monoclonal mouse antibody for 15–30 min. After washing with buffer solution, Dako REAL EnVision Detection System was used to label the antigen.

All statistical analyses were performed using SPSS software version 17.0 (SPSS Inc., IBM, Chicago, IL, USA). Histological node positivity was the primary end point in the study. Student’s t test was used for nonparametric variables and the χ2 test was used for categorical variables with the level of significance set at p < 0.05. The odds ratio was computed in univariate and multivariate settings using logistic regression analysis.

A total of 97 carcinoma penis patients underwent surgical management at our institute during the abovementioned period. The mean follow-up period of the patients was 23 months (1 month–47 months) and 2 patients were lost to follow-up. The clinicopathological characteristics of the patients are presented in Table 1.

Table 1.

Clinicopathological characteristics of the patients

Clinicopathological characteristics of the patients
Clinicopathological characteristics of the patients

Logistic regression was applied to the above data and grade III tumor, presence of lymphovascular invasion (LVI), tumor thickness >10 mm, perineural invasion (PNI) and Ki67 >50% were significantly associated with nodal metastasis (Table 2). On multivariate analysis (Table 3), only presence of PNI was found to be significant (odds ratio: 6.82) (95% confidence interval: 1.72–27.03) (p = 0.006).

Table 2.

Univariate analysis of factors predicting nodal metastasis

Univariate analysis of factors predicting nodal metastasis
Univariate analysis of factors predicting nodal metastasis
Table 3.

Multivariate analysis for factors predicting nodal positivity

Multivariate analysis for factors predicting nodal positivity
Multivariate analysis for factors predicting nodal positivity

Lymph node involvement is one the most important prognostic factors in penile cancer. The 5 year survival drops to 51% with the involvement of inguinal nodes, and it is dismal with involvement of pelvic nodes [6]. The incidence of occult metastasis in a clinically negative node is around 10–20% [7]. It becomes imperative to identify occult nodal metastasis as early lymphadenectomy has been shown to improve cancer-specific survival and can be curative for histologically node positive patients [8]. Though various noninvasive methods have been attempted to identify inguinal node involvement, none have been proven effective. Historically, clinical examination has been associated with false positive rate of 50%. Ultrasound-guided fine needle aspiration cytology has false negative rate is 15%. CT or MRI is not recommended for detecting occult metastasis [7]. Hence, in a clinically negative groin, invasive methods have been used to identify occult metastasis. However, this leads to nearly 60% negative inguinal nodal dissections and unnecessary morbidity of skin edge necrosis, scrotal, or limb edema associated with it [9]. Currently, the guidelines recommend invasive staging in clinically negative groin based on primary tumor stage, grade of the tumor, and presence of LVI. We conducted a retrospective review to identify factors in the primary tumor which predicts lymph node metastasis.

Histological grade has been consistently seen as an important predictor of lymph nodal metastasis. The frequency of nodal metastasis increases from 9–47.5% to 67–85% as grade increases from I to III [7]. In a previous study from our institute, histological grade was the most significant factor for predicting nodal metastasis [10]. Aita et al. [11] demonstrated a better survival for low-grade cancers. An important caveat noted with grade determination is the interobserver variation and reproducibility [12]. Although at our place, the incidence of penile carcinoma is high and the pathologist was experienced, it may be a challenge for centers where these cases are scarcely encountered.

On evaluating the National Cancer Database, Winters et al. [13] found LVI as the strongest independent predictor of occult lymph node metastasis. A similar suggestion has been made by other authors also [14, 15]. Grade and presence of LVI have also been included in the EAU risk stratification for clinically node negative disease. However, as noted by Graafland et al. [16], 77% of the EAU high-risk patients would undergo a negative bilateral lymphadenectomy, leading to additional morbidity [16]. This underlines the search for additional predictive factors and a better risk stratification.

Perineurium forms the covering layer for nerve fascicles formed by flattened fibroblast and acts as a protective sheath. Since the perineural space is devoid of blood or lymphatics, cancer cells can theoretically breach this barrier at 2 anatomical locations, including distal nerve endings and entry points of epineural vessels. Once the barrier is breached, tumor cells can access the central nervous system [17]. The significance of PNI in penile cancer was demonstrated by Velazquez et al. [18] who defined it as tumor infiltrating the clear and open perineural space, and found it to be a significant predictor of nodal metastasis along with histological grade. They created a nomogram using these factors and found 80% probability of nodal metastasis for grade III tumors with PNI [18]. In another study, PNI was found to be predictive of local recurrence after glansectomy, along with grade and positive margins [19]. The presence of PNI has also been correlated with poor survival [20]. In our study also, PNI has proven to be a significant predictor of lymph node metastasis on multivariate analysis. A recent meta-analysis has shown an increased risk of inguinal lymph node metastasis and a higher cancer-specific mortality associated with presence of PNI especially in younger patients [21]. Even though various authors have questioned its role as an independent prognostic factor, it has been included in the AJCC TNM 8th edition staging manual [11, 22, 23].

Similar to that in malignant melanoma, Emerson et al. [24] suggested the role of depth of invasion in penile cancer and tumor progression. Ficarra et al. [14] included it in their nomogram for predicting prognosis; however, further studies have revealed its ambiguity as a prognostic factor with various authors suggesting different outcomes [25]. In our study, increasing depth of invasion was associated with increasing risk of nodal metastasis with depth >1 cm showing statistical significance in univariate analysis. Probably, a larger sample size would bring more clarity to its role.

The limitation of histological markers in predicting nodal metastasis has shifted the attention toward molecular markers. One of the markers under evaluation is Ki67, which is regarded as a marker of proliferation and its presence may signify aggressive disease as suggested by a correlation with tumor grade [26]. Zhu et al. [27] tried to determine its prognostic significance in penile cancer with a threshold for Ki67 set at 20%. They reported a significant correlation between expression of Ki67 and lymph node metastasis on univariate analysis but not on multivariate analysis [27]. A similar finding has been seen in our cohort also. In another study, where a cutoff of 40% was taken, there was strong correlation between Ki67 and tumor grade; however, no association was seen with lymph node metastasis or stage [26].

Advanced tumor stage and infiltrating pattern of invasion showed trend toward poorer prognosis, but were not significant on univariate analysis. Various authors have studied other molecular and biochemical markers, like p53, DNA binding protein inhibitor-1, superoxide dismutase 2 and squamous cell carcinoma antigen overexpression, matrix metalloproteinase-9, high e-cadherin, higher neutrophil to lymphocyte ratio, diffuse PD-L1 expression, and C-reactive protein >20, but further validation studies are required before incorporating them to clinical practice [15, 27, 28]. Our study is limited by its retrospective nature, small sample size and patients being treated at different time periods during which the understanding of the disease changed considerably leading to use of different modalities. Ours is a single-center experience thereby restricting its applicability. Currently a risk-adapted strategy is increasingly used by many centers which lead to unnecessary surgery. This strategy based on the characteristics of primary tumors needs further refinement, and addition of molecular markers will probably lead to better stratification. In our study, PNI appeared to be the strongest predictor; however, larger prospective studies are required to search for more accurate predictors of nodal metastasis.

Primary tumor characteristics, including high grade, LVI, PNI, tumor thickness >1 cm, and Ki67 >50% were significantly associated with nodal metastasis in penile cancer. PNI emerged to be the strongest independent predictor and its presence should suggest occult lymph node metastasis.

The study design complies with the Declaration of Helsinki ethical standards. The study protocol was approved by Cancer Institute (WIA) Institutional Ethics Committee (Reference No: IEC/2021/July 07) Written informed consent was obtained from all the participants.

The authors have no conflicts of interest to declare.

The authors have no financial support to declare.

A.R. and N.K. are responsible for conception and design, drafting the article, critical revision of the article, and final approval of the version to be published. K.M. and D.C. performed the data collection, analysis, and interpretation and drafted the article.

The data that support the findings of this study are available on request from the corresponding author.

1.
Harish
K
,
Ravi
R
.
The role of tobacco in penile carcinoma
.
Br J Urol
.
1995
;
75
:
375
7
. .
2.
Hakenberg
OW
,
Compérat
EM
,
Minhas
S
,
Necchi
A
,
Protzel
C
,
Watkin
N
.
EAU guidelines on penile cancer: 2014 update
.
Eur Urol
.
2015
;
67
:
142
50
. .
3.
Misra
S
,
Chaturvedi
A
,
Misra
NC
.
Penile carcinoma: a challenge for the developing world
.
Lancet Oncol
.
2004
;
5
:
240
7
. .
4.
Kathiresan
N
,
Raja
A
,
Ramachandran
KK
,
Sundersingh
S
.
Role of dynamic sentinel node biopsy in carcinoma penis with or without palpable nodes
.
Indian J Urol
.
2016
;
32
:
57
60
. .
5.
Leijte
JAP
,
Kirrander
P
,
Antonini
N
,
Windahl
T
,
Horenblas
S
.
Recurrence patterns of squamous cell carcinoma of penis: recommendation for follow-up based on a two-centre analysis of 700 patients
.
Eur Urol
.
2008
;
54
:
161
8
.
6.
Pandey
D
,
Mahajan
V
,
Kannan
RR
.
Prognostic factors in node-positive carcinoma of the penis
.
J Surg Oncol
.
2006
;
93
:
133
8
. .
7.
Horenblas
S
.
Lymphadenectomy for squamous cell carcinoma of the penis. Part 1: diagnosis of lymph node metastasis
.
BJU Int
.
2001
;
88
:
467
72
. .
8.
Correa
AF
,
Handorf
E
,
Joshi
SS
,
Geynisman
DM
,
Kutikov
A
,
Chen
DY
,
Differences in survival associated with performance of lymph node dissection in patients with invasive penile cancer: results from the national cancer database
.
J Urol
.
2018
;
199
:
1238
44
. .
9.
Senthil Kumar
MP
,
Ananthakrishnan
N
,
Prema
V
.
Predicting regional lymph node metastasis in carcinoma of the penis: a comparison between fine-needle aspiration cytology, sentinel lymph node biopsy and medial inguinal lymph node biopsy
.
Br J Urol
.
1998
;
81
:
453
7
. .
10.
Ramkumar
A
,
Seshadri
RA
,
Narayanaswamy
K
,
Balasubramanian
S
.
Risk factors for lymph node metastasis in clinically node-negative penile cancer patients
.
Int J Urol
.
2009
;
16
(
4
):
383
7
. .
11.
Aita
GA
,
Zequi
SC
,
Costa
WH
,
Guimarães
GC
,
Soares
FA
,
Giuliangelis
TS
.
Tumor histologic grade is the most important prognostic factor in patients with penile cancer and clinically negative lymph nodes not submitted to regional lymphadenectomy
.
Int Braz J Urol
.
2016
;
42
:
1136
43
. .
12.
Naumann
CM
,
Alkatout
I
,
Hamann
MF
,
Al-Najar
A
,
Hegele
A
,
Korda
JB
,
Interobserver variation in grading and staging of squamous cell carcinoma of the penis in relation to the clinical outcome
.
BJU Int
.
2009
;
103
:
1660
5
. .
13.
Winters
BR
,
Mossanen
M
,
Holt
SK
,
Lin
DW
,
Wright
JL
.
Predictors of nodal upstaging in clinical node negative patients with penile carcinoma: a national cancer database analysis
.
Urology
.
2016
;
96
:
29
34
. .
14.
Ficarra
V
,
Akduman
B
,
Bouchot
O
,
Palou
J
,
Tobias-Machado
M
.
Prognostic factors in penile cancer
.
Urology
.
2010
;
76
:
S66
73
. .
15.
Zekan
DS
,
Dahman
A
,
Hajiran
AJ
,
Luchey
AM
,
Chahoud
J
,
Spiess
PE
.
Prognostic predictors of lymph node metastasis in penile cancer: a systematic review
.
Int Braz J Urol
.
2021 Sep–Oct
;
47
(
5
):
943
56
. .
16.
Graafland
NM
,
Lam
W
,
Leijte
JA
,
Yap
T
,
Gallee
MP
,
Corbishley
C
,
Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients
.
Eur Urol
.
2010
;
58
:
742
7
. .
17.
Piña-Oviedo
S
,
Ortiz-Hidalgo
C
.
The normal and neoplastic perineurium: a review
.
Adv Anat Pathol
.
2008
;
15
(
3
):
147
64
. .
18.
Velazquez
EF
,
Ayala
G
,
Liu
H
,
Chaux
A
,
Zanotti
M
,
Torres
J
,
Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm
.
Am J Surg Pathol
.
2008
;
32
(
7
):
974
9
. .
19.
Albersen
M
,
Parnham
A
,
Joniau
S
,
Sahdev
V
,
Christodoulidou
M
,
Castiglione
F
,
Predictive factors for local recurrence after glansectomy and neoglans reconstruction for penile squamous cell carcinoma
.
Urol Oncol
.
2018
;
36
(
4
):
141
6
. .
20.
Vale
L
,
Fernandes
B
,
Rodrigues
V
,
Dinis
P
,
Silva
C
,
Antunes-Lopes
T
.
Prognostic factors in penile cancer: should we avoid inguinal lymph node staging?
Urol Int
.
2021
;
105
(
9–10
):
799
803
. .
21.
Zhou
X
,
Qi
F
,
Zhou
R
,
Wang
S
,
Wang
Y
,
Wang
Y
,
The role of perineural invasion in penile cancer: a meta-analysis and systematic review
.
Biosci Rep
.
2018
;
38
(
5
):
BSR20180333
. .
22.
Nascimento
ADMTD
,
Pinho
JD
,
Júnior
AALT
,
Larges
JS
,
Soares
FM
,
Calixto
JRR
,
Angiolymphatic invasion and absence of koilocytosis predict lymph node metastasis in penile cancer patients and might justify prophylactic lymphadenectomy
.
Medicine
.
2020
;
99
:
e19128
. .
23.
Paner
GP
,
Stadler
WM
,
Hansel
DE
,
Montironi
R
,
Lin
DW
,
Amin
MB
.
Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers
.
Eur Urol
.
2018
;
73
(
4
):
560
9
. .
24.
Emerson
RE
,
Ulbright
TM
,
Eble
JN
,
Geary
WA
,
Eckert
GJ
,
Cheng
L
.
Predicting cancer progression in patients with penile squamous cell carcinoma: the importance of depth of invasion and vascular invasion
.
Mod Pathol
.
2001
;
14
(
10
):
963
8
. .
25.
Alkatout
I
,
Naumann
CM
,
Hedderich
J
,
Hegele
A
,
Bolenz
C
,
Jünemann
KP
,
Squamous cell carcinoma of the penis: predicting nodal metastases by histologic grade, pattern of invasion and clinical examination
.
Urol Oncol
.
2011
;
29
(
6
):
774
81
. .
26.
Berdjis
N
,
Meye
A
,
Nippgen
J
,
Dittert
D
,
Hakenberg
O
,
Baretton
GB
,
Expression of Ki-67 in squamous cell carcinoma of the penis
.
BJU Int
.
2005
;
96
(
1
):
146
8
. .
27.
Zhu
Y
,
Zhou
XY
,
Yao
XD
,
Dai
B
,
Ye
DW
.
The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery
.
BJU Int
.
2007
;
100
(
1
):
204
8
. .
28.
Hu
J
,
Cui
Y
,
Liu
P
,
Zhou
X
,
Ren
W
,
Chen
J
,
Predictors of inguinal lymph node metastasis in penile cancer patients: a meta-analysis of retrospective studies
.
Cancer Manag Res
.
2019
;
11
:
6425
41
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.